Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways - Concepedia

Concepedia

Publication | Open Access

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways

DOI Full Paper Access

51

Citations

20

References

2022

Year

Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju‐Hee Oh, Hyun Sung Kim

Clinical and Molecular Hepatology

Abstract

Auranofin inhibits lipogenesis and fibrosis formation and is a proposed candidate for NASH treatment.

References

	Year	Citations

Page 1